associ
viral
mycoplasma
pneumonia
infect
acut
exacerb
chronic
bronchiti
studi
serolog
isol
techniqu
adult
men
five
year
serolog
evid
viral
pneumonia
infect
detect
episod
exacerb
remiss
period
p
influenza
viru
parainfluenza
viru
type
coronaviru
predomin
infect
virus
infrequ
infect
pneumonia
detect
serolog
four
patient
organ
never
isol
sputum
specimen
rhinovirus
isol
frozenstor
sputum
specimen
episod
exacerb
remiss
interv
p
signific
data
suggest
although
exacerb
chronic
bronchiti
may
accompani
viral
pneumonia
infect
patient
chronic
bronchiti
also
acquir
infect
without
worsen
respiratori
statu
microorgan
infect
respiratori
tract
recov
individu
undergo
exacerb
chronic
bronchiti
howev
role
viral
mycoplasm
infect
exacerb
chronic
bronchiti
fulli
document
moreov
observ
regard
infect
chronic
bronchit
design
patient
popul
specifi
period
may
compar
popul
high
preval
morbid
chronic
bronchiti
among
patient
veteran
administr
hospit
conduct
surveil
one
group
assess
impact
respiratori
tract
infect
natur
cours
diseas
investig
occurr
rel
import
virus
mycoplasma
exacerb
evid
viral
mycoplasma
pneumonia
infect
obtain
mainli
serolog
test
lesser
extent
isol
organ
correl
pattern
clinic
diseas
patient
chronic
bronchiti
design
studi
fortysix
male
adult
chronic
bronchiti
outpati
veteran
administr
hospit
hine
ill
constitut
studi
group
patient
fulfil
criteria
diagnosi
chronic
bronchiti
defin
chronic
recurr
increas
volum
mucoid
mucopurul
bronchial
secret
suffici
caus
expector
least
three
month
two
year
prior
entri
studi
group
clinic
microbiolog
statu
studi
longitudin
five
year
monthli
altern
month
period
exacerb
patient
report
outpati
clinic
examin
visit
symptom
questionnair
complet
examin
physic
examin
perform
pulmonari
function
test
done
sputum
specimen
collect
isol
viru
mycoplasma
serum
specimen
obtain
serolog
evalu
questionnair
definit
remiss
exacerb
model
guidelin
report
medic
research
council
exacerb
defin
increas
cough
sputum
product
sinc
patient
previou
visit
symptom
upper
airway
infect
includ
among
criteria
exacerb
consid
satisfactorili
test
viral
pneumonia
infect
serum
pair
obtain
episod
sputum
specimen
collectedior
mycoplasm
viral
isol
one
hundr
sixtysix
exacerb
test
manner
comparison
interv
patient
experi
exacerb
otherwis
remiss
similarli
test
popul
characterist
patient
veteran
attend
pulmonari
outpati
clinic
regular
basi
visit
clinic
monthli
followup
averag
month
per
year
made
averag
total
visit
per
year
person
habitu
poor
attend
includ
studi
popul
age
patient
begin
studi
period
rang
year
distribut
age
follow
year
two
patient
year
year
nine
year
year
nine
median
age
decad
year
patient
cigarett
smoker
rang
packyear
one
pack
per
man
per
year
five
median
year
pulmonari
function
test
entri
studi
disclos
mark
degre
obstruct
pulmonari
diseas
mean
valu
forc
vital
capac
fvc
forc
expiratori
volum
fev
ratio
fev
liter
liter
express
percentag
normal
fev
studi
patient
rang
twothird
group
valu
similarli
fev
ratio
rang
normal
twothird
group
valu
procedur
isol
viru
sputum
specimen
viral
isol
store
c
five
eight
year
readi
use
specimen
rapidli
thaw
ml
suspend
ml
chill
veal
infus
broth
treat
unit
penicillin
rrnl
soo
p
g
streptomycin
rml
mg
amphotericin
b
ml
broth
hr
c
volum
ml
treat
sputum
suspens
inocul
two
rollertub
cultur
human
diploid
fibroblast
strain
recoveri
picornavirus
adenovirus
herpesvirus
coronaviru
strain
long
period
storag
sputum
specimen
attempt
made
isol
myxovirus
rollertub
cultur
obtain
flow
laboratori
rockvil
md
mainten
medium
cell
cultur
consist
eagl
minim
essenti
medium
supplement
inactiv
fetal
calf
serum
complet
medium
adjust
ph
cultur
incub
rotat
drum
c
least
day
often
long
day
subpassag
neg
cultur
made
cell
cultur
examin
three
time
week
cpe
mainten
medium
chang
time
viral
isol
vere
identifi
procedur
previous
describ
mycoplasma
fresh
agar
medium
consist
pleuropneumonialik
organ
agar
difco
detroit
mich
hors
serum
yeast
extract
penicillin
g
unitsj
ml
amphotericin
b
jlgml
thallium
acet
use
isol
mycoplasma
duplic
plate
inocul
sputum
one
plate
incub
aerob
anerob
c
four
week
mycoplasma
isol
identifi
growth
inhibit
procedur
use
specif
hyperirnmun
antiserum
includ
test
antisera
pneumonia
mycoplasma
oral
mycoplasma
homini
mycoplasma
errnentan
mycoplasma
arthrid
mycoplasma
salioarium
approxim
onehalf
cultur
passag
agar
second
time
area
select
adjac
zone
inhibit
attempt
identifi
mix
cultur
mycoplasma
none
detect
serolog
procedur
serial
serum
specimen
test
cf
antibodi
influenza
b
virus
respiratori
syncyti
viru
rsv
parainfluenza
viru
type
adenovirus
coronaviru
type
pneumonia
microtit
cf
test
contain
unit
complement
employ
fixat
overnight
c
four
unit
viral
mycoplasm
antigen
use
serolog
evid
infect
defin
fourfold
greater
rise
antibodi
titer
acuteand
convalescentphas
sera
occurr
acut
respiratori
ill
patient
chronic
bronchiti
total
number
exacerb
experienc
patient
particip
studi
rang
one
mean
number
exacerb
anyon
patient
usual
directli
proport
number
year
particip
surveil
program
mean
number
year
patient
particip
one
patient
report
exacerb
fouryear
period
studi
exacerb
chronic
bronchi
ti
tend
occur
often
winter
month
summer
month
although
occur
frequent
month
year
tabl
serolog
evid
viral
pneumonia
infect
infect
respiratori
viru
pneumonia
detect
least
patient
studi
mean
ber
infect
rang
although
patient
includ
studi
longer
time
experienc
somewhat
viru
pneumonia
infect
relationship
linear
find
suggest
individu
differ
rate
infect
could
attribut
exclus
durat
particip
studi
fourfold
greater
rise
titer
antibodi
viru
pneumonia
detect
exacerb
chronic
bronchiti
adult
patient
studi
tabl
comparison
viral
pneumonia
infect
detect
remiss
rate
significantli
differ
suggest
patient
chronic
bronchiti
undergo
infect
agent
appar
without
acut
worsen
respiratori
statu
rise
titer
antibodi
multipl
agent
occur
simultan
singl
episod
exclud
analysi
distribut
singleag
infect
could
assess
tabl
infect
defin
rise
titer
antibodi
singl
agent
viru
pneumonia
detect
exacerb
chronic
bronchiti
remiss
differ
signific
p
frequenc
individu
viral
pneumonia
infect
analyz
use
singleag
antibodi
titer
rise
tabl
fortyon
rise
antibodi
titer
exacerb
singleag
antibodi
titer
rise
remiss
rise
singleag
antibodi
titer
rise
higher
incid
multipleag
antibodi
titer
rise
remiss
interv
may
reflect
studi
design
attent
paid
specimen
collect
exacerb
result
averag
interv
defin
avail
serum
pair
month
exacerb
month
remiss
myxoviru
coronaviru
infect
predomin
tabl
influenza
viru
parainfluenza
viru
type
coronaviru
account
nearli
twothird
infect
instanc
infect
occur
often
exacerb
remiss
find
suggest
associ
occurr
exacerb
chronic
bronchiti
howev
differ
signific
influenza
viru
coronaviru
p
viral
infect
occur
often
exacerb
remiss
pneumonia
infect
alon
occur
exacerb
remiss
fifteen
addit
rise
titer
antibodi
pneumonia
occur
simultan
respiratori
viru
infect
rise
equal
distribut
period
exacerb
remiss
viral
infect
among
patient
chronic
bronchiti
occur
defin
outbreak
figur
studi
viral
pneumonia
infect
common
patient
exacerb
infect
occur
also
patient
without
worsen
respiratori
statu
report
find
two
way
rise
titer
antibodi
singl
agent
rise
titer
antibodi
two
agent
within
interv
rise
titer
antibodi
multipl
agent
predomin
remiss
interv
tend
longer
exacerb
interv
differ
may
account
variat
antibodi
titer
indic
specif
viral
infect
antibodi
titer
rise
multipl
agent
also
may
reflect
heterotyp
respons
overestim
number
infect
analyz
antibodi
titer
rise
singl
agent
report
estim
import
infect
specif
viru
approach
preclud
assess
role
dual
infect
two
virus
viru
pneumonia
exacerb
rise
titer
antibodi
pneumonia
howev
detect
often
associ
titer
rise
one
respiratori
virus
possibl
pneumonia
function
secondari
synergist
pathogen
respiratori
tract
infect
exclud
requir
investig
virus
may
playa
role
exacerb
chronic
bronchiti
suggest
find
onefourth
exacerb
associ
viral
infect
rate
twice
viral
infect
remiss
infect
influenza
viru
coronaviru
occur
significantli
often
exacerb
remiss
coronavirus
recogn
recent
etiolog
agent
respiratori
ill
children
adult
gump
cowork
also
report
associ
agent
exacerb
chronic
bronchiti
found
four
seven
infect
coronaviru
two
seven
infect
coronaviru
associ
exacerb
evid
relationship
accumul
slowli
requir
recoveri
strain
human
fetal
trachea
organ
cultur
difficult
procedur
infect
coronaviru
detect
either
isola
tion
rise
antibodi
titer
patient
studi
find
studi
rhinoviru
infect
exacerb
consider
lower
recoveri
rate
rhinovirus
exacerb
report
eadi
carilli
et
al
howev
fail
isol
agent
control
studi
stenhous
found
rhinoviru
infect
common
subject
bronchiti
control
popul
rhinoviru
infect
like
associ
develop
acut
lower
respiratori
tract
symptom
extend
period
frozen
storag
specimen
tissu
cultur
inocul
may
contribut
low
recoveri
rate
rhinovirus
sommervil
first
detect
rsv
infect
exacerb
carilli
et
al
mcnamara
et
al
also
found
rsv
associ
signific
number
exacerb
respect
unlik
investig
detect
rsv
infect
serolog
procedur
one
remiss
interv
one
patient
pauciti
pneumonia
infect
detect
exacerb
studi
agre
result
anoth
recent
report
number
prospect
studi
pneumonia
infect
associ
exacerb
exacerb
one
consist
find
howev
failur
recov
organ
sputum
even
patient
rise
antibodi
titer
result
question
signific
serolog
respons
alon
infect
investig
saliuarium
seem
ubiquit
sampl
expector
sputum
well
specimen
obtain
bronchoscopi
find
similar
report
number
studi
viral
pneumonia
infect
exacerb
chronic
bronchiti
tabl
variou
studi
rate
infect
exacerb
rang
wide
data
interpret
constitut
strong
conclus
evid
etiolog
role
virus
pneumonia
pathogenesi
acut
exacerb
chronic
bronchiti
howev
avail
data
easili
compar
differ
sampi
procedur
method
employ
addit
individu
author
often
specifi
number
remiss
interv
examin
report
infect
detect
exacerb
compar
patient
chronic
bronchiti
healthi
control
popul
furthermor
definit
exacerb
subject
judgment
differ
interpret
criteria
affect
percentag
associ
infect
two
group
investig
deriv
strike
correl
infect
exacerb
interpret
find
timeweight
fashion
thu
gump
et
al
found
incid
infect
per
patient
week
exacerb
per
patient
week
spent
remiss
similarli
lami
et
al
compar
patient
month
spent
exacerb
remiss
incid
infect
respect
data
permit
timeweight
analysi
sinc
durat
exacerb
record
durat
exacerb
estim
use
interv
collect
two
sampl
serum
bracket
exacerb
test
month
exacerb
month
remiss
rate
viral
infect
per
exacerb
month
per
remiss
month
trend
similar
data
gump
et
al
special
problem
interpret
pose
detect
infect
patient
chronic
bronchiti
without
associ
acut
compromis
respiratori
statu
studi
approxim
onethird
viral
pneumonia
infect
detect
belong
categori
whether
subclin
infect
contribut
continu
clinic
deterior
remain
unexplor
longterm
epidemiolog
clinic
surveil
patient
chronic
bronchiti
requir
answer
question
